Hence, combining LPA axis inhibitors with immune checkpoint blockade could reverse immunosuppression, elicit anti-tumor immunity, and yield synergistic effects
In 2025, Novo's obesity-care sales rose 31% at constant exchange rates to DKK 82.3 billion, and the company reported a 59.6% global branded volume share in obesity
IV therapyan innovative treatment that delivers fluids, vitamins, or medications directly into your bloodstreamcan offer significant benefits when administered by our experienced healthcare professionals
We explore these issues and more in this edition of Deep Dive on Affordable Housing
We saw average cost savings of $6,396 per GLP-1 patient, driven by decreases in avoidable imaging (93%) and high-cost diagnostic procedures (90%) Combined with an average reduction of 64% in ER visits across Oshis full patient population, the savings for buyers were substantial